Phillygenin inhibits LPS induced proinflammatory response and Lx2 cell activation through TLR4/MyD88/NF-κB signaling pathway, thereby inhibiting HF (Hu et al., 2020b). The gene discussed is TLR4; the disease is hydrops fetalis.